Bid purchasing of radiopharmaceuticals and radiopaque contrast media
Use of product standardization and competitive-bid purchasing for radiopharmaceuticals and radiopaque contrast media in a 1000-bed teaching hospital is described. The hospital's use of radiopharmaceuticals was reviewed, and all agents were listed with their product specifications and order quantity or frequency. Manufacturers and wholesalers were asked to submit unit prices for each of their products. Similar procedures were followed for radiopaque contrast media; wholesalers and manufacturers were asked to submit unit prices that would be guaranteed for a 12-month contract period. A nuclear pharmacist and radiologists reviewed the submitted bids and awarded contracts, basing their decisions primarily on product acceptability and selection criteria and then on relative costs of the agents. Annual costs were reduced 16% ($16,500) for radiopharmaceuticals and 21.3% ($66,500) for radiopaque contrast media. The program also resulted in decreased inventory of radiopaque contrast media and in faster and less expensive acquisition of emergency orders. Working with the radiology department to compile a standard list of radiopharmaceuticals and radiopaque contrast media and soliciting competitive bids by vendors of these products resulted in annual savings of more than $83,000.
- Research Organization:
- Henry Ford Hospital, Detroit, MI
- OSTI ID:
- 5020051
- Journal Information:
- Am. J. Hosp. Pharm.; (United States), Vol. 7
- Country of Publication:
- United States
- Language:
- English
Similar Records
All-source bidding: The purchased power market in flux
Robust bidding strategy for aggregation of distributed prosumers in flexiramp market
Related Subjects
CONTRAST MEDIA
SALES
RADIOPHARMACEUTICALS
COST
HOSPITALS
INVENTORIES
MARKETING
MICHIGAN
RADIOLOGY
STANDARDIZATION
BUILDINGS
DRUGS
FEDERAL REGION V
LABELLED COMPOUNDS
MEDICAL ESTABLISHMENTS
MEDICINE
NORTH AMERICA
NUCLEAR MEDICINE
USA
550601* - Medicine- Unsealed Radionuclides in Diagnostics